Biswas B N, Rudra A, Mandal S K
Department of Anaesthesiology, Bankura Sammilani Medical College & Hospital.
J Indian Med Assoc. 2003 Nov;101(11):638, 640, 642.
Laparoscopic tubal ligation is associated with an appreciably high rate of postoperative nausea and vomiting. This study was designed to compare the effectiveness of ondansetron, dexamethasone, ondansetron plus dexamethasone or placebo in the prevention of postoperative nausea and vomiting in patients after laparoscopic tubal ligation. In a prospective, randomised, double blind placebo controlled trial, 160 ASA I-II females received one of four regimens; ondansetron 4 mg, dexamethasone 8 mg, ondansetron 4 mg plus dexamethasone 8 mg or placebo (n=40 each) intravenously immediately before induction of anaesthesia. Patients were then observed for 24 hours postoperatively. The incidence of emetic episodes in the ondansetron with dexamethasone group was lower than in the placebo (p<0.001) and ondansetron (p=0.091) and dexamethasone (p=0.143) groups. A complete response (as no postoperative nausea and vomiting) was achieved in 60% of patients given ondansetron, 63% of the patients given dexamethasone, 78% of patients given ondansetron with dexamethasone and 37% of patients received placebo. The prophylactic use of ondansetron with dexamethasone is more effective in preventing postoperative nausea and vomiting.
腹腔镜输卵管结扎术后恶心呕吐的发生率相当高。本研究旨在比较昂丹司琼、地塞米松、昂丹司琼加地塞米松或安慰剂在预防腹腔镜输卵管结扎术后患者恶心呕吐方面的效果。在一项前瞻性、随机、双盲、安慰剂对照试验中,160例ASA I-II级女性患者接受了四种治疗方案之一;在麻醉诱导前立即静脉注射4毫克昂丹司琼、8毫克地塞米松、4毫克昂丹司琼加8毫克地塞米松或安慰剂(每组40例)。然后对患者术后24小时进行观察。昂丹司琼加地塞米松组的呕吐发作发生率低于安慰剂组(p<0.001)、昂丹司琼组(p=0.091)和地塞米松组(p=0.143)。接受昂丹司琼治疗的患者中有60%、接受地塞米松治疗的患者中有63%、接受昂丹司琼加地塞米松治疗的患者中有78%以及接受安慰剂治疗的患者中有37%实现了完全缓解(即无术后恶心呕吐)。预防性使用昂丹司琼加地塞米松在预防术后恶心呕吐方面更有效。